The enzyme operates via a proton abstraction-readdition mechanism:
Substrate Binding: GlcA residues adjacent to N-sulfated glucosamine are positioned in the active site .
Epimerization: Tyr residues abstract the C5 proton, inducing a conformational shift to form IdoA .
Reversibility: Reaction equilibrium favors IdoA formation in vivo but is reversible in vitro .
Biological Role: Essential for HS chain flexibility, enabling interactions with growth factors, cytokines, and extracellular matrix proteins .
Disease Relevance:
Comparative activity of recombinant hse-5 under varying conditions :
| Substrate | Activity (nmol/min/mg) | Optimal Conditions |
|---|---|---|
| Heparin-derived oligosaccharides | 0.8–1.2 | 30°C, 1 mM TCEP, 0.1% Tween 20 |
| K5 polysaccharide | 0.5–0.9 | pH 7.4, reducing environment required |
Activity is enhanced by reducing agents (e.g., TCEP) and detergents (e.g., Tween 20) .
Chemoenzymatic Synthesis: Used to produce heparin-like glycosaminoglycans for therapeutic studies .
Kinetic Studies: Real-time NMR and HPLC methods quantify IdoA/GlcA ratios during catalysis .
Structural Biology: Apo- and substrate-bound crystal structures inform drug design targeting HS-related diseases .